Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H34O6 |
Molecular Weight | 406.5125 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]3C[C@@H](O)CC(=O)O3)OC(=O)[C@@H](C)CC
InChI
InChIKey=OQARDMYXSOFTLN-PZAWKZKUSA-N
InChI=1S/C23H34O6/c1-4-13(2)23(27)29-20-11-16(24)9-15-6-5-14(3)19(22(15)20)8-7-18-10-17(25)12-21(26)28-18/h5-6,9,13-14,16-20,22,24-25H,4,7-8,10-12H2,1-3H3/t13-,14-,16+,17+,18+,19-,20-,22-/m0/s1
Pravastatin Lactone is a metabolite of pravastatin. Pravastatin is HMG-CoA reductase inhibitor and it is primarily used for the treatment of dyslipidemia and the prevention of cardiovascular disease. Pravastatin and pravastatin-lactone uptake is liver cell specific. Pravastatin-lactone uptake into isolated rat liver cells is carrier mediated. The mutual competitive transport inhibition of bile acids and pravastatin and pravastatin-lactone in sodium-free medium indicates that these compounds share a common transport system. Pravastatin lactone, based on its lipophilicity, showed a high myotoxic potential.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3471 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24954548 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone. | 1993 Nov 21 |
|
Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin. | 1999 Aug |
|
Quantitative determination of pravastatin and its biotransformation products in human serum by turbo ion spray LC/MS/MS. | 2000 Oct |
|
Effects of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese. | 2004 Apr |
|
Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro. | 2008 Apr 23 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8241247
Pravastatin-lactone is not accumulated into AS-30D ascites hepatoma cells, FAO cells or fibroblasts. Pravastatin-lactone uptake rates were 1053 pmol/mg per min for hepatocytes, 2 pmol/mg per min for AS-30D ascites cells and 10 pmol/mg per rain for fibroblasts.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9931182
Created by
admin on Sat Dec 16 08:43:09 GMT 2023 , Edited by admin on Sat Dec 16 08:43:09 GMT 2023
|
PRIMARY | |||
|
85956-22-5
Created by
admin on Sat Dec 16 08:43:09 GMT 2023 , Edited by admin on Sat Dec 16 08:43:09 GMT 2023
|
PRIMARY | |||
|
DTXSID70235286
Created by
admin on Sat Dec 16 08:43:09 GMT 2023 , Edited by admin on Sat Dec 16 08:43:09 GMT 2023
|
PRIMARY | |||
|
JBE3Z4192Q
Created by
admin on Sat Dec 16 08:43:09 GMT 2023 , Edited by admin on Sat Dec 16 08:43:09 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD